|
|
||||||||||||||
|
|
|||||||||||||||
|
British Journal of Ophthalmology 2005;89:1418-1419; doi:10.1136/bjo.2005.073700 Copyright © 2005 by the BMJ Publishing Group Ltd.
The pharmacokinetics of linezolid in the non-inflamed human eyeJ I Prydal1, D R Jenkins2, A Lovering3, A Watts4
1 Department of Ophthalmic Surgery, University Hospitals of Leicester NHS Trust, Leicester LE1 5WW, UK
Correspondence to:
Method: Patients undergoing routine cataract surgery were given a single oral 600 mg dose of linezolid at a variable time before surgery. Aqueous and serum levels of linezolid were assayed by high performance liquid chromatography, and a pharmacokinetic curve constructed from the pooled results. Results: Orally administered linezolid rapidly achieves levels in the aqueous of non-inflamed eyes that exceed the concentration required to kill Gram positive bacteria (maximum mean concentration 6.8 (SD 1.2) µg/ml at 24 hours post-dose). An effective concentration is maintained for at least 12 hours, the standard interdose interval for this antimicrobial. Conclusion: Linezolid offers the possibility of a rapid, oral approach to effective treatment of most cases of postoperative endophthalmitis, with the potential of improving visual outcome.
Abbreviations: HPLC, high performance liquid chromatography; MIC, minimal inhibitory concentration; POE, postoperative endophthalmitis Keywords: linezolid; pharmacokinetics; endophthalmitis
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |